Review
The present role of prostatic specific antigen (PSA) as a tumor marker in carcinoma of the prostate
Affiliations
- PMID: 1712422
Item in Clipboard
Review
The present role of prostatic specific antigen (PSA) as a tumor marker in carcinoma of the prostate
Mo Med.
1991 Jun.
Abstract
Prostatic specific antigen (PSA) is an important tumor marker for prostate cancer and is being used more frequently in men suspected of having this disease. Although PSA cannot be recommended by itself for either screening or staging of prostate cancer, its present role is discussed by the author.
Similar articles
-
Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.Anticancer Res. 1988 Jul-Aug;8(4):569-72. Anticancer Res. 1988. PMID: 2460018
-
Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.J Lab Clin Med. 1989 May;113(5):598-603. J Lab Clin Med. 1989. PMID: 2469756
-
[Prostatic specific antigen and prostatic pathology. Value of preoperative blood assay. Preliminary study apropos of 709 case reports].Ann Urol (Paris). 1989;23(4):295-300. Ann Urol (Paris). 1989. PMID: 2480077 French.
-
Prostate cancer-associated markers.Immunol Ser. 1990;53:339-56. Immunol Ser. 1990. PMID: 1713065 Review.
-
Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.Scand J Urol Nephrol Suppl. 1994;162:73-87; discussion 115-27. Scand J Urol Nephrol Suppl. 1994. PMID: 7529430 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous